InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Murray Mark Christopher, Directeur des Biomatériaux. Insider active across 1 company, notably Avantor, Inc.. In total, 2 disclosures have been logged. History available since 13 January 2022. The latest transaction was filed on 13 January 2022 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Declarations2 total
918 shares@ US$37.500.0004% mcap50.0% of flowCommon StockSEC:0001722482-22-000014:0
918 shares@ US$37.500.0004% mcap100.0% of flowCommon StockSEC:0001722482-22-000014
2 of 2 declarations
About Murray Mark Christopher
Murray Mark Christopher is the Executive Vice President of Biomaterials & AT at Avantor, Inc. He oversees initiatives related to biomaterials and technological innovation. His expertise is essential for developing advanced solutions in the sector.
